Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather M Long

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Nature Immunology|December 1, 2022
Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4<sup>+</sup> T cell recognitionEmily X C Tye, Elizabeth Jinks, Tracey A Haigh, et al.
Blood|July 31, 2010
A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapyChristopher P Fox, Tracey A Haigh, Graham S Taylor, et al.
Journal of Virology|August 25, 2017
Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult CasesRachel J Abbott, Annette Pachnio, Isabela Pedroza-Pacheco, et al.
Journal of Extracellular Vesicles|February 10, 2024
Bioengineered small extracellular vesicles deliver multiple SARS-CoV-2 antigenic fragments and drive a broad immunological responseHannah K Jackson, Heather M Long, Juan Carlos Yam-Puc, et al.
Plos Pathogens|March 28, 2015
Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African childrenShamanthi Jayasooriya, Thushan I de Silva, Jainaba Njie-jobe, et al.
Cell Reports|March 3, 2023
Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent mannerGuerman Molostvov, Mariam Gachechiladze, Abeer M Shaaban, et al.
The Journal of Pathology|March 5, 2020
The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancerSteven Hayward, Mariam Gachehiladze, Nahla Badr, et al.
Nature Immunology|March 6, 2021
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
Nature Immunology|May 21, 2021
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
Nature Immunology|August 4, 2016
CXCR5(+) follicular cytotoxic T cells control viral infection in B cell folliclesYew Ann Leong, Yaping Chen, Hong Sheng Ong, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature Immunology|December 1, 2022
Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4<sup>+</sup> T cell recognitionEmily X C Tye, Elizabeth Jinks, Tracey A Haigh, et al.
Blood|July 31, 2010
A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapyChristopher P Fox, Tracey A Haigh, Graham S Taylor, et al.
Journal of Virology|August 25, 2017
Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult CasesRachel J Abbott, Annette Pachnio, Isabela Pedroza-Pacheco, et al.
Journal of Extracellular Vesicles|February 10, 2024
Bioengineered small extracellular vesicles deliver multiple SARS-CoV-2 antigenic fragments and drive a broad immunological responseHannah K Jackson, Heather M Long, Juan Carlos Yam-Puc, et al.
Plos Pathogens|March 28, 2015
Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African childrenShamanthi Jayasooriya, Thushan I de Silva, Jainaba Njie-jobe, et al.
Cell Reports|March 3, 2023
Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent mannerGuerman Molostvov, Mariam Gachechiladze, Abeer M Shaaban, et al.
The Journal of Pathology|March 5, 2020
The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancerSteven Hayward, Mariam Gachehiladze, Nahla Badr, et al.
Nature Immunology|March 6, 2021
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
Nature Immunology|May 21, 2021
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infectionJianmin Zuo, Alexander C Dowell, Hayden Pearce, et al.
Nature Immunology|August 4, 2016
CXCR5(+) follicular cytotoxic T cells control viral infection in B cell folliclesYew Ann Leong, Yaping Chen, Hong Sheng Ong, et al.
Pageof 5